Mechanism of combined use of vitamin D and puerarin in anti-hepatic fibrosis by regulating the Wnt/β-catenin signalling pathway

Table 3 The mRNA levels of collagen I, collagen III, Wnt1, and β-catenin of liver

Groups	Collagen I	Collagen III	Wnt1	β-catenin
C	1.17 ± 0.16bcde	0.62 ± 0.15bcde	0.56 ± 0.13bcde	0.48 ± 0.21bcde
CCl4	4.73 ± 0.76acde	2.47 ± 1.12acde	1.77 ± 0.32acde	2.16 ± 0.42acde
V	1.97 ± 0.31b	1.29 ± 0.19ab	1.06 ± 0.35ab	1.25 ± 0.33ab
P	1.75 ± 0.46b	1.35 ± 0.17ab	0.83 ± 0.19ab	0.71 ± 0.46ab
V + P	1.53 ± 0.12abcd	1.03 ± 0.08abcd	0.61 ± 0.24abcd	0.59 ± 0.14abcd

Differences are considered to exhibit statistical significance when P < 0.05 (n = 10) in the comparison of the mean ± standard deviation (SD) between various groups. a, b, c, d, and e indicate that there are statistical differences vs C, CCl₄, V, P, and V + P groups, respectively. C: Control; V: Vitamin; P: Puerarin.